Pharmaceutical otoprotection strategies to prevent impulse noise-induced hearing loss

One of the ongoing challenges for hearing researchers is successful protection of the ear from noise injury. For decades, the most effective methods have been based on modifying the acoustic properties of the noise, either by reducing noise output from various sources, interfering in the acoustic ex...

Full description

Bibliographic Details
Main Authors: Bielefeld, E.C (Author), Harrison, R.T (Author), Riley Debacker, J. (Author)
Format: Article
Language:English
Published: Acoustical Society of America 2019
Subjects:
Online Access:View Fulltext in Publisher
LEADER 02822nam a2200469Ia 4500
001 10.1121-1.5132285
008 220511s2019 CNT 000 0 und d
020 |a 00014966 (ISSN) 
245 1 0 |a Pharmaceutical otoprotection strategies to prevent impulse noise-induced hearing loss 
260 0 |b Acoustical Society of America  |c 2019 
856 |z View Fulltext in Publisher  |u https://doi.org/10.1121/1.5132285 
520 3 |a One of the ongoing challenges for hearing researchers is successful protection of the ear from noise injury. For decades, the most effective methods have been based on modifying the acoustic properties of the noise, either by reducing noise output from various sources, interfering in the acoustic exposure path with environmental controls, or altering the noise dose for the individual with personal hearing protection devices. Because of the inefficiencies of some of the acoustic modification procedures, pharmaceutical otoprotection is targeted at making the cochlea less susceptible to injury. Short-duration, high-level impulse noises, typically caused by small-scale explosions, cause different sets of injuries in the ear than long-duration, low-variance noise exposures. Therefore, the expectation is that the ears exposed to impulse noise may need different pharmaceutical interventions, both in type of compounds used and the time course of administration of the compounds. The current review discusses four different classes of compounds that have been tested as impulse noise otoprotectants. In the process of describing those experiments, particular emphasis is placed on the acoustic properties of the impulses used, with the goal of providing context for evaluating the relevance of these different models to human impulse noise-induced hearing loss. © 2019 Acoustical Society of America. 
650 0 4 |a Acoustic exposure 
650 0 4 |a Acoustic modifications 
650 0 4 |a Acoustic noise 
650 0 4 |a Acoustic properties 
650 0 4 |a animal 
650 0 4 |a Animals 
650 0 4 |a antioxidant 
650 0 4 |a Antioxidants 
650 0 4 |a Audition 
650 0 4 |a Different class 
650 0 4 |a Environmental control 
650 0 4 |a glucocorticoid 
650 0 4 |a Glucocorticoids 
650 0 4 |a Hearing Loss, Noise-Induced 
650 0 4 |a human 
650 0 4 |a Humans 
650 0 4 |a Impulse noise 
650 0 4 |a magnesium 
650 0 4 |a Magnesium 
650 0 4 |a neuroprotective agent 
650 0 4 |a Neuroprotective Agents 
650 0 4 |a Noise induced hearing loss 
650 0 4 |a noise injury 
650 0 4 |a Personal hearing protection device 
650 0 4 |a Short durations 
650 0 4 |a Small-scale explosions 
700 1 |a Bielefeld, E.C.  |e author 
700 1 |a Harrison, R.T.  |e author 
700 1 |a Riley Debacker, J.  |e author 
773 |t Journal of the Acoustical Society of America